Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Inventory Average (2019 - 2025)

Historic Inventory Average for Sunshine Biopharma (SBFM) over the last 7 years, with Q3 2025 value amounting to $13.5 million.

  • Sunshine Biopharma's Inventory Average rose 4789.86% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 4789.86%. This contributed to the annual value of $8.5 million for FY2024, which is 8851.44% up from last year.
  • Sunshine Biopharma's Inventory Average amounted to $13.5 million in Q3 2025, which was up 4789.86% from $12.4 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Inventory Average registered a high of $13.5 million during Q3 2025, and its lowest value of $25215.5 during Q1 2021.
  • Its 5-year average for Inventory Average is $4.8 million, with a median of $4.0 million in 2023.
  • Per our database at Business Quant, Sunshine Biopharma's Inventory Average skyrocketed by 233776.06% in 2023 and then surged by 4789.86% in 2025.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Inventory Average stood at $88480.0 in 2021, then soared by 1911.52% to $1.8 million in 2022, then soared by 188.01% to $5.1 million in 2023, then skyrocketed by 105.81% to $10.5 million in 2024, then grew by 28.36% to $13.5 million in 2025.
  • Its last three reported values are $13.5 million in Q3 2025, $12.4 million for Q2 2025, and $11.6 million during Q1 2025.